2nd Annual International Congress on Immunotherapies in Cancer : Focus on Practice-Changing Application
In-Person Event
Dec 16, 2017
New York City, New York, USA
OVERVIEW
2nd Annual International Congress on Immunotherapies in Cancer : Focus on Practice-Changing Application is organized by Physicians Education Resource, LLC (PER) and will be held on Dec 16, 2017 at InterContinental New York Times Square, New York, United States Of America.
Target Audience :
This educational program is directed toward oncologists, nurses, and pharmacists. Participants will be primarily those whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on immunotherapies and their evolving roles in the treatment of cancer. This CME Conference has been approved for a maximum of 6.5 AMA PRA Category 1 Credits.
Course Overview :
The development of immunotherapies to treat cancer has transformed the way clinicians think about managing their patients with many forms of malignancies. The speed at which basic science and clinical trial information continue to emerge in this area, however, creates practice and/or educational gaps for busy clinicians who strive to maintain state-of-the-art care for their patients with cancer. This field is one of the most clinically relevant and exciting areas of novel drug development in oncology.
Learning Objectives :
After completing this educational activity, the participants will be able to:
• Explain current and evolving mechanistic approaches concerning how the immune system can be targeted in the treatment of cancer.
• Evaluate clinical trial findings on immuno-oncology strategies and how they can be practically applied to the management of cancer in multiple lines of care.
• Discuss emerging methods to personalize care via the use of biomarkers and other methods to individualize the use of immuno-oncology strategies.
• Describe how common and uncommon adverse events, associated with the use of immuno-oncology strategies, can be proactively mitigated and managed.
• Detail important remaining clinical questions in the field, and highly anticipated ongoing clinical trials, that are evaluating emerging immuno-oncology strategies.
Additional details will be posted as soon as they are available.
Target Audience :
This educational program is directed toward oncologists, nurses, and pharmacists. Participants will be primarily those whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on immunotherapies and their evolving roles in the treatment of cancer. This CME Conference has been approved for a maximum of 6.5 AMA PRA Category 1 Credits.
Course Overview :
The development of immunotherapies to treat cancer has transformed the way clinicians think about managing their patients with many forms of malignancies. The speed at which basic science and clinical trial information continue to emerge in this area, however, creates practice and/or educational gaps for busy clinicians who strive to maintain state-of-the-art care for their patients with cancer. This field is one of the most clinically relevant and exciting areas of novel drug development in oncology.
Learning Objectives :
After completing this educational activity, the participants will be able to:
• Explain current and evolving mechanistic approaches concerning how the immune system can be targeted in the treatment of cancer.
• Evaluate clinical trial findings on immuno-oncology strategies and how they can be practically applied to the management of cancer in multiple lines of care.
• Discuss emerging methods to personalize care via the use of biomarkers and other methods to individualize the use of immuno-oncology strategies.
• Describe how common and uncommon adverse events, associated with the use of immuno-oncology strategies, can be proactively mitigated and managed.
• Detail important remaining clinical questions in the field, and highly anticipated ongoing clinical trials, that are evaluating emerging immuno-oncology strategies.
Additional details will be posted as soon as they are available.
KEY DATES
16 Dec, 2017
Event Start Date
16 Dec, 2017
Event End Date
SPECIALITIES
OncologySUGGESTED HOTELS
CONFERENCE VENUE
InterContinental New York Times SquareRELATED CONFERENCES & LIVE WEBINARS
Quick Links